Gene editing: The next frontier in America’s abortion wars
By Sarah Karlin,
Politico
| 02. 16. 2016
[cites CGS' Marcy Darnovsky]
Untitled Document
Longtime combatants find themselves on the same side when it comes to manipulating the DNA of human embryos.
That may seem like an idea from a sci-fi flick, but it’s already here. The gene-editing technique is already used in research and has the potential to modify human DNA with unprecedented ease in the not-too-distant future. British regulators approved limited experiments in human embryos earlier this month.
The technology holds promise to cure diseases like cystic fibrosis or sickle cell and even revive extinct species. But critics fear it could also be harnessed to craft “designer babies,” who are more intelligent, beautiful or athletic and to “edit” embryonic cells to change an inherited trait forever.
Those dystopian prospects have aligned U.S. groups long at odds: The anti-abortion Susan B. Anthony List, Family Research Council and the Center for Bioethics and Culture oppose gene editing in embryos. So do abortion rights groups like Our Bodies Ourselves and the leadership of the Pro Choice Alliance for Responsible Research, albeit for very different reasons.
They’re not alone in raising concerns. Scientists...
Related Articles
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...